Roivant Sciences Ltd. · NASDAQ:ROIV
Morgan Stanley reported a 8.00% stake in Roivant Sciences Ltd. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 11, 2026
Morgan Stanley reported a 8.00% stake in Roivant Sciences Ltd., 55,491,570 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G/A).
- Stake
- 8.00%
- Shares
- 55,491,570
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Morgan Stanley | 8.00% | 55,491,570 |
| Morgan Stanley Investment Management Inc. | 7.80% | 54,403,260 |
Source
Related
- Roivant Sciences Ltd.
- Morgan Stanley
- Roivant Sciences Ltd. shareholders
- Schedule 13G/A · Morgan Stanley · Aug 13, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G · Morgan Stanley · Aug 7, 2025
- Form 4 · Sukhatme Mayukh · Oct 20, 2026
- Form 4 · Gline Matthew · Oct 20, 2026
- Form 4 · Epperly Melissa B, · Oct 5, 2026
- Form 4 · Venker Eric · Oct 2, 2026
- Form 4 · Torti Frank · Oct 2, 2026